OrsoBio Announces Publication of Preclinical Data on Novel Approach for Regulating Metabolic Dysfunction and Reducing Inflammation and Fibrosis by Seini Moimoi | Oct 15, 2024 | Portfolio News
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares by Seini Moimoi | Oct 15, 2024 | Portfolio News
BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private Placement by Seini Moimoi | Oct 1, 2024 | Portfolio News
Poseida Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for P-BCMA-ALLO1 to Treat Relapsed/Refractory Multiple Myeloma by Seini Moimoi | Sep 16, 2024 | Portfolio News
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering by Seini Moimoi | Sep 12, 2024 | Portfolio News
